
Leadership
Shai Novik
Shai Novik has spent his career building, financing and selling companies in the public markets.
He is the co-founder and Executive Chairman of Enlivex Therapeutics (Nasdaq: ENLV). In 2005 he founded PROLOR Biotech, which he managed through its U.S. stock-exchange listing in 2010 and its sale in 2013 in a transaction valued at $560 million.
Earlier he was Chief Operating Officer, Head of Strategic Planning and Head of the Investment Committee at THCG, a New York technology and life-sciences venture capital firm. He holds an M.B.A. with distinction from Cornell University.
- Today
- Co-founder and Executive Chairman, Enlivex Therapeutics (Nasdaq: ENLV)
- Before
- Founder, PROLOR Biotech (2005). Listed in the U.S. in 2010, sold in 2013
- Earlier
- Chief Operating Officer, THCG (venture capital, New York)
- Education
- M.B.A. with distinction, Cornell University
Biography based on the published Enlivex Therapeutics management profile.